Organization · Venture Capital
Vine Ventures
Vine Ventures is an early-stage venture capital fund focused on psychedelic-assisted therapies and mental health innovation, based in the US and Switzerland. The organization commits 50% of its profits to mental health philanthropy.
Overview
What Vine Ventures does
What Vine Ventures is
Vine Ventures is an early-stage venture capital fund focused on psychedelic-assisted therapies and mental health innovation, based in the US and Switzerland. The organization commits 50% of its profits to mental health philanthropy.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2020
- Approximate age
- About 6 years
- Structured capabilities
- Funder
- Last reviewed
- March 27, 2026
Official channels
Find Vine Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Vine Ventures as a funder
Investment thesis
Vine Ventures invests in novel modalities for mental health and wellbeing, particularly in psychedelic-assisted therapies, with a commitment to ethical and community-focused practices.
Focus narrative
Vine Ventures invests primarily in the life sciences sector, with a strong emphasis on psychedelic science and mental health. The organization seeks to support companies that are pioneering new approaches to mental health and wellness, particularly those that prioritize accessibility and ethical practices.
Value beyond capital
Vine Ventures adds value to its portfolio companies by providing not only capital but also governance participation in philanthropic efforts, ensuring that founders have a voice in the allocation of funds to mental health initiatives. The firm leverages its deep expertise in venture capital and its commitment to ethical practices to support the growth and impact of its investments.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A
- Sectors
- Biotech & Life SciencesHealthcareMental Health & BehavioralArtificial IntelligenceHealth PlatformsDigital Health
- Regions
- Global · United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 32
Portfolio context
Notable portfolio companies include: Othership - a mobile app and community space focused on breathwork and mental health; Bright Minds - engaged in psychedelic research; Lykos Therapeutics - specializing in MDMA-assisted therapy; Psygen - a manufacturer of psychedelic APIs; Bexson Biomedical - focused on ketamine therapeutics; Tripp - offering VR wellness experiences; Gilgamesh Pharmaceuticals - developing next-gen psychedelic compounds; and Clerkenwell Health - conducting UK-based psychedelic clinical research.
Common questions
What to know about Vine Ventures
Upseed classifies Vine Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.